- Briefing Your roundup of Asian tech and startup news that matter
Singapore biotech firm raises $30m for US expansion
TurtleTree, a Singapore-based biotech startup, has raised US$30 million in the first tranche of its latest funding round.
More funding details
- Lead investor: Verso Capital
- Stage: Series A
More company updates
- The round pushes TurtleTree’s total amount raised from investors to date to over US$40 million. The company says that the latest round marks one of the largest investments for a cell-based food company in Asia.
- TurtleTree will use the fresh money for hiring and research purposes.
- The funds will also help the firm’s expansion to the US, following the launch of a research and development facility in Sacramento last September.
- In December last year, the company raised US$6.2 million in pre-series A funding from Green Monday Ventures, Eat Beyond Global, KBW Ventures, and Verso Capital.
For more coverage of the company, head here. You can also click on the link below to view key details about the company as well as its funding history.
Editing by Miguel Cordon and Lorenzo Kyle Subido
(And yes, we’re serious about ethics and transparency. More information here.)
Stay updated on the go with our mobile app.
Get latest insights with smoother, more personalized experience through TIA mobile app.





